US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Lophos Pharma
Recent news which mentions Lophos Pharma
Experts Discuss Botanical Psilocybin's Effect On Neurogenesis And More At Benzinga Cannabis Conference
April 29, 2024
Tickers
CCC
NEWS
Tags
peyote
It’s All About Choices
Cannabis
From
Benzinga
Meet The Company Developing Innovative Peyote-Based Treatments For Addiction, Anxiety, And Depression
April 29, 2022
Tags
Benzinga
Market News
Markets
From
Benzinga
G2 Buys Peyote-Focused Psychedelics Company Lophos Pharma
January 24, 2022
Tags
Psychedelics Company
Claire Stawnyczy
Markets
From
Benzinga